Clinical trial
Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica
NCT04537338 is registered in ClinicalTrials.gov with Agencia Costarricense de Investigaciones Biomedicas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica
- Lead sponsor
- Agencia Costarricense de Investigaciones Biomedicas
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 14, 2020
- Completion date
- September 14, 2022
- Enrollment
- 2,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.